See the DrugPatentWatch profile for dexamethasone
What is dexamethasone's primary use for inflammation?
Dexamethasone is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It's widely used to treat various inflammatory conditions, including [1] severe allergies, asthma, rheumatoid arthritis, and multiple sclerosis. As a medication, dexamethasone has both systemic and topical forms, allowing for localized or general treatment, depending on the application site and severity of the condition.
Why is dexamethasone effective against inflammation?
Dexamethasone works by inhibiting the activity of phospholipase A2, a key enzyme involved in the production of inflammatory mediators. By blocking this enzyme, dexamethasone reduces the production of prostaglandins, leukotrienes, and other pro-inflammatory molecules. As a result, it effectively decreases inflammation, swelling, and other associated symptoms in various conditions.
How is dexamethasone used in clinical practice?
Dexamethasone can be administered through various routes, including intravenous infusion, injection, tablet, capsule, and topical formulations. The dosage and treatment duration depend on the condition being treated and the individual's response to the medication. In some cases, dexamethasone may be used as a long-term prophylactic to prevent inflammation or as a short-term treatment to manage acute flare-ups.
What forms of dexamethasone are available?
Dexamethasone is available in various formulations, including [2]:
- Oral tablets and capsules
- Intravenous infusions
- Topical creams and ointments
- Ear drops
- Eye drops and ointments
The choice of formulation depends on the specific condition being treated and the individual patient's needs.
Patent information
The patent for dexamethasone expired in the United States, allowing generic and biosimilar versions of the medication to enter the market. According to DrugPatentWatch.com, the patent for dexamethasone phosphate, a common intravenous form of the medication, expired in 1995 [3].
Sources:
[1] Mayo Clinic. Dexamethasone. Published August 26, 2022. https://www.mayoclinic.org/drugs-supplements/dexamethasone/art-20365711
[2] National Institutes of Health. Dexamethasone. Published November 2022. https://www.ncbi.nlm.nih.gov/books/NBK536923/
[3] DrugPatentWatch.com. Dexamethasone Phosphate Patent Expiration Date in United States. Accessed May 2024.